Acute kidney injury after early enteral nutrition in patients with hip fracture: A quality-improvement audit
Published
April 28, 2025
Paper ID
PAP-000172
Status
Published
DOI
10.65712/tmj.test000430
Advance Services
Abstract
Background: Guidelines make only a weak recommendation on early enteral nutrition. Methods: Analyses were adjusted for age, sex and baseline severity. Results: Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.77 (95% CI 0.28 to 0.73). Conclusion: Residual confounding cannot be excluded.
Introduction
Guidelines make only a weak recommendation on early enteral nutrition. Earlier studies of early enteral nutrition were small or single-centre.
acute kidney injury remains a leading cause of avoidable harm among patients with hip fracture. Guidelines make only a weak recommendation on early enteral nutrition.
acute kidney injury remains a leading cause of avoidable harm among patients with hip fracture. Guidelines make only a weak recommendation on early enteral nutrition. Practice around early enteral nutrition varies widely between centres.
Guidelines make only a weak recommendation on early enteral nutrition. Earlier studies of early enteral nutrition were small or single-centre.
Discussion
These findings suggest that early enteral nutrition is associated with better acute kidney injury in patients with hip fracture. Implementation will depend on staffing, cost and local protocols. Future work should test early enteral nutrition in a pragmatic multicentre trial.
Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded.
Conclusions
Early enteral nutrition merits wider use for patients with hip fracture to improve acute kidney injury.
References
1. Nakamura F, Haddad F, et al. Home-based cardiac rehabilitation and post-operative delirium. Lancet. 2016;43(4):767-1105.
2. Volkov U, Patel D, et al. Delayed cord clamping and ventilator-free days. Eur Heart J. 2021;70(9):258-1199.
3. Larsen N, Kowalski P, et al. Point-of-care ultrasound and patient satisfaction. Eur Heart J. 2019;154(3):432-1748.
4. Zhang P, Schmidt S, et al. Vitamin D supplementation and 30-day readmission. N Engl J Med. 2015;243(7):408-1037.
5. Costa A, Costa S, et al. Low-dose aspirin and in-hospital mortality. Diabetes Care. 2017;24(10):1-1796.
6. Dubois S, Andersen J, et al. An antibiotic stewardship programme and health-related quality of life. Diabetes Care. 2021;240(2):870-1700.
Appendices
The statistical analysis plan is in the online supplement.
Materials and Methods
Eligible participants were patients with hip fracture.
Analyses were adjusted for age, sex and baseline severity. Eligible participants were patients with hip fracture.
Eligible participants were patients with hip fracture. The primary outcome was acute kidney injury, assessed blind to allocation.
Eligible participants were patients with hip fracture. The primary outcome was acute kidney injury, assessed blind to allocation.
Results
Serious adverse events were rare and similar between groups. acute kidney injury occurred in 15% of the intervention group versus 37% of controls. The adjusted odds ratio was 0.51 (95% CI 0.29 to 0.73).
Effects were consistent across prespecified subgroups. acute kidney injury occurred in 12% of the intervention group versus 12% of controls. Serious adverse events were rare and similar between groups.
| Group | n | Events | Rate % | OR |
|---|---|---|---|---|
| Age < 65 | 784 | 73 | 25.5 | 0.86 |
| Control | 610 | 14 | 25.6 | 0.53 |
| Centre A | 370 | 112 | 3.3 | 0.84 |
| Female | 71 | 26 | 22.9 | 0.76 |
Values are n (%) unless stated otherwise.

Shown for patients with hip fracture; error bars are 95% confidence intervals.

Shown for patients with hip fracture; error bars are 95% confidence intervals.
acute kidney injury occurred in 13% of the intervention group versus 19% of controls. The adjusted odds ratio was 0.53 (95% CI 0.22 to 0.91). acute kidney injury occurred in 13% of the intervention group versus 26% of controls. 338 participants were included (median age 35 years).
Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.60 (95% CI 0.24 to 0.63). Effects were consistent across prespecified subgroups.